Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Denosumab Antibody (5H762) is a Mouse antibody targeting Denosumab. Anti-Denosumab Antibody (5H762) can be used in ELISA, Competitive ELISA.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 40 μg | $305 | 7-10 days | 7-10 days |
| Description | Anti-Denosumab Antibody (5H762) is a Mouse antibody targeting Denosumab. Anti-Denosumab Antibody (5H762) can be used in ELISA, Competitive ELISA. |
| Synonyms | Prolia Xgeva, Prolia, AMG-162, AMG 162 |
| Ig Type | IgG1,κ |
| Clone | 5H762 |
| Specificity | Denosumab |
| Verified Activity | 1. ELISA binding of Anti-Denosumab Antibody (5H762) (TMAS-00032) with Denosumab. While the antibody does not recognize the human IgG (data not shown). Coating antigen: Denosumab, 1 µg/ml. Anti-Denosumab Antibody (5H762) (TMAS-00032) dilution start from 1,000 ng/ml. EC50= 2.921 ng/ml. 2. Anti-Denosumab Antibody (5H762) (TMAS-00032) blocks Denosumab binding with Human RANKL recombinant protein. Coating antigen: Denosumab 1 µg/ml. RANKL final concentration: 12.5 ng/ml. Anti-Denosumab antibody dilutions start from 30 μg/ml. IC50= 0.893 µg/ml. 3. Standard curve of Denosumab Sandwich ELISA. The Denosumab Sandwich ELISA assay is developed by using Anti-Denosumab Antibody (6S249) (TMAS-00030) and Anti-Denosumab Antibody (5H762) (TMAS-00032) as the capture and detection antibodies, respectively. In this ELISA assay, Anti-Denosumab Antibody (5H762) (TMAS-00032) was labeled with Biotin. The sensitivity of detecting Denosumab is up to 0.26 ng/ml. |
| Application | |
| Recommended Dose | ELISA: 0.001-0.05 µg/ml; Competitive ELISA: 5-30 µg/ml |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Purification | Protein A affinity column |
| Appearance | Lyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml. |
| Formulation | Lyophilized with PBS, pH 7.2, containing 0.02% sodium azide. |
| Research Background | Denosumab with trade name Prolia, is an FDA-approved drug for the treatment of patients with osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. Denosumab is a fully human monoclonal antibody that works as a RANK ligand (RANKL) inhibitor. Denosumab can bind RANKL, preventing RANKL from activating RANK, its receptor on the osteoclast surface. |
| Conjucates | Unconjugated |
| Immunogen | Denosumab |
| Stability & Storage | The lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.